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Abstract
Introduction and objectives: Early detection of prostate cancer (PCa) with prostate-specific antigen (PSA)
has led to a stage migration with increased detection of early stage, potentially curable disease. Knowledge
about PSA screening for PCa among men will lead to increased detection of potentially curable disease.
Subjects and methods: Male public servants in Anambra State, Southeast, Nigeria, were invited to complete
a self-administered questionnaire on their knowledge of PCa and PSA screening. Results were analyzed
using Microsoft Excel® 2007.
Results: A total of 652 men completed the questionnaire. Their mean age was 45.1 years (range 20–69).
Overall, 74.1% of the respondents were aware of the existence of PCa, while 76.1% were able to identify one
or more symptoms of the disease. Difficulty in passing urine was identified as the most common presenting
symptom by 45.3% of the respondents, while 87% were able to identify risk factors for PCa. Whereas
56.7% were aware of PSA screening and 92% expressed interest in having PCa screening if recommended
only 6.4% had undergone PSA screening in the preceding year.
Conclusion: Despite a high awareness of PCa among public servants in Anambra State, Nigeria, a very
small proportion of these men had undergone PSA screening. To achieve a stage migration in PCa detection
in Nigeria, early detection using PSA screening should be actively driven by health personnel using the
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ntroduction
rostate cancer (PCa) is the second commonest cause of cancer-
elated death in men worldwide [1]. Logically, it would be expected
hat early detection should lead to a reduction in cancer-related mor-
ality as seen in other genitourinary tumors such as testicular cancer,
ense.ut this is not the case with PCa [2].
n Nigeria, like other developing countries in sub-Saharan Africa,
here is no national cancer mortality database or active screening
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Table 1 Knowledge of PCa and PSA screening.
Knowledge Aware/positive response Not aware/negative response
Number Percentage Number Percentage
Aware of PCa 483 74.1 169 25.9
Positive family history 125 19.2 527 80.8
Possible symptoms 496 76.1 156 23.9
Possible risk factors 567 87 85 13
Aware of PSA screening 370 56.8 282 43.2
4 610 93.6
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Data on cancer morbidity and mortality in Nigeria are unavailable
due to the absence of a national cancer registry. However, a review of
Table 2 Sources of information on PCa and PSA screening.
Source of information Response rate
Number PercentageScreened during past year 42 6.
Willing to be screened 600 92
program [3], which makes it difficult to assess the true burden of
PCa. However, studies in Nigeria emphasize the increasing preva-
lence of the disease [4,5]. Most cases are diagnosed late, patients
are less likely to receive curative therapy, and the commonest mode
of therapy is androgen deprivation [4,6,7].
The role of PCa screening with prostate-specific antigen (PSA) is
controversial, because early detection has not been shown clearly
to decrease PCa mortality [8]. Nonetheless, PSA screening for PCa
has been widely used since its approval by the United States Food
and Drug Administration in 1994 [9].
The aim of this study was to assess the knowledge of PCa and PSA
screening among male public servants in Anambra State, Southeast
Nigeria.
Subjects and methods
Male public servants in Anambra State were enlisted into the study
after providing informed consent. The study consisted of a self-
administered questionnaire testing 7 key areas of PCa knowledge
and PSA screening:
1. Awareness of PCa
2. Presenting symptoms
3. Risk factors
4. Awareness of screening with PSA
5. Performance of screening with PSA
6. Sources of information on PCa and PSA screening
7. Willingness to undergo PSA test if recommended
Each question was scored with one point for a correct answer, with
a total of 7 points as the maximum score. Results were analyzed
using Microsoft Excel® 2007.
Results
A total of 652 men completed the questionnaire. The mean age of
the respondents was 45.1 years (range 20–69). Most of the men
(38.8%) were in the age group 40–49 years (Fig. 1). The over-
all knowledge score based on the 7-part questionnaire was 4.11
(58.7%). The results of the questionnaire are shown in Table 1.
Difficulty in passing urine was identified as the most common
presenting symptom by 45.3% of respondents. Other symptoms
included back pain, hematuria and pyuria, identified by 12%, 12.5%
and 6.2%, respectively, whereas 23.9% did not know any symptomsFigure 1 Age distribution of respondents.
ssociated with PCa. Risk factors for PCa identified by the respon-
ents were age, presence of testes, diet and family history – 28.2%,
4.9%, 12.6% and 21.2%, respectively. The sources of information
n PCa and PSA screening identified by the respondents are shown
n Table 2.
iscussion
Ca is the most commonly diagnosed malignancy among men,
nd the peak incidence is in the sixth to seventh decades of life
1,4,6]. The disease has a profound emotional and functional effect
n patients and their caregivers and imposes a large financial burden.
Ca incidence in Nigeria (127/100.000) is comparable to that in
frican American men, with an annual death rate of about 20.000
5]. With the increasing life expectancy in Nigeria, more men will
e diagnosed with PCa [10].Friend 128 19.6
Doctor/health worker 240 36.8
Books/newspapers/magazines 276 42.3
Television/radio 279 42.8
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ancer morbidity in adults from Ibadan, Southwest Nigeria, showed
hat PCa was the most common cancer in males [11].
n this study, there was a high level of knowledge (74.1%) of PCa
mong male public servants in Anambra State, Nigeria. This may
e attributed to higher education levels and greater access to infor-
ation among these men. There are conflicting reports concerning
ublic awareness of PCa in different parts of Nigeria [12,13]. The
eported differences can be explained by differences in the popula-
ion groups studied.
his study cohort of well educated public servants in full-time
mployment represents a small fraction of the population, who
re largely uneducated [14]. One may reasonably expect a bet-
er appreciation of health matters in this group of men than in
he general population. Due to its selection bias, this study may
ot reflect general population trends and attitudes. This indicates
he need for studying the general population, although the study
ubjects may not be able to complete the questionnaire without
ssistance.
hereas 56.8% of the respondents had knowledge of PSA screening
or PCa, only 6.4% had undergone PSA screening in the preceding
ear, although 90% were willing to undergo PSA testing if recom-
ended. This may be related to the credibility of health promotion
ampaigns or the fear of being diagnosed with cancer. In Nigeria,
here is no national policy on PCa screening, and most public health
nformation is not directed at early detection and treatment. The low
creening rate in this study population will invariably translate into
lower rate of early detection of PCa.
SA screening definitely leads to stage migration with increased
iagnosis of early stage, potentially curable PCa [15]. However,
he population benefit of PSA screening for PCa remains unproven
16], although multinational studies have reported decreasing PCa
ortality rates in countries with more widespread screening policies
16].
onclusion
here is a high awareness of PCa and PSA screening among male
ublic servants in Anambra State, Nigeria. To achieve stage migra-
ion in PCa detection in Nigeria, early detection using PSA screening
hould be actively driven by health personnel using the media, and
hould be backed with an effective national health policy on PCa
creening.
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